Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Alopecia areata treatments often cause headaches and infections, highlighting the need for safer options.

Eclipta alba may improve memory and help treat Alzheimer's disease.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Upadacitinib may effectively treat alopecia areata without side effects.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Squaric acid dibutylester effectively treats alopecia areata.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.